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A SYNTHETIC PEPTIDE BASED on the second transmembrane segment of the glycine receptor (M2GlyR) has been shown to form an anion-selective pathway in epithelial cells that allows for electrolyte secretion when applied to the apical surface (26) . This activity represents a potential therapeutic modality for the treatment of cystic fibrosis (CF) and provides impetus for ongoing development. M2GlyR has been modified to increase aqueous solubility while maintaining channel-forming ability and anion selectivity (NK 4 -M2GlyR and CK 4 -M2GlyR; Refs. 2, 33) . Several derivatives of this sequence have been shown to be effective at increasing short-circuit current (I sc ), an indicator of net anion secretion (2, 3, 31) . Studies employing modified peptides suggest that the NH 2 -terminal half of the transmembrane segment contributes to intramembrane helical bundle formation, whereas the COOH-terminal half of the segment is responsible for aggregation in aqueous solution (3) . Thus a peptide has been designed and synthesized (KKKK-PARVGLGITTVLVTTIGLGVRAP; designated NC-1059) in which the transmembrane portion of the molecule is a palindrome of the bundle-forming, nonaggregating, NH 4 -terminal portion around the central leucine. NC-1059 elicits an increase in I sc at low micromolar concentrations and remains monomeric in aqueous solution (3) . NK 4 -M2GlyR requires a fourfold higher concentration than NC-1059 to support anion flux [EC 50 ϭ 208 Ϯ 6 M (2) vs. 50 Ϯ 3 M (3)]. Thus NC-1059 appears to exhibit all targeted attributes for a CF therapeutic (monomeric, soluble, low cytotoxicity). Additionally, NC-1059 causes an increase in the transepithelial electrical conductance (g TE ) across Madin-Darby canine kidney (MDCK) monolayers, which might suggest an effect on the paracellular pathway and specifically on tight junctions. This latter effect, which has not been reported previously for any synthetic peptide, appears to preclude the palindromic peptide from further consideration as a CF therapeutic. However, NC-1059 represents a possible tool to study or manipulate the epithelial barrier.
Tight junctions are complex, highly regulated, dynamic structures that are a barrier to movement of solutes between apical and basolateral compartments and form a "fence" that maintains cell membrane polarity (4, 37) . Regulated openings of junctions occur in a variety of situations such as sperm maturation (18) , extravasation of lymphocytes (8) , and nutrient uptake in the intestine (23) . Pathology associated with aberrant function and dysregulation of tight junctions includes cancer metastases (16) , autoimmune dysfunction (20) , and inflammatory bowel disease (12) , to name just a few. Tight junctions are targets of bacterial toxins such as the Vibrio cholerae zonula occludens toxin (ZOT) and Clostridium difficile toxins TcdA and TcdB (36) in pathological, experimental, and perhaps therapeutic situations (9, 10) . A mammalian homolog of ZOT has been identified and may be a primary physiological regulator of tight junctions in intestinal tissues (36) . Additionally, cytokines and a number of second messengers are known to be involved in the modulation of tight junctions (8, 9, 14, 34, 37) , although the mechanisms by which these processes occur remain to be elucidated.
A variety of treatments, including Ca 2ϩ chelation, surfactants, fatty acids, and cationic polymers, have been used to experimentally modulate the paracellular pathway (17, 37) . However, when applied in vivo, side effects of the chemical treatments used to modulate g TE can include hypersensitivity, asthma, anaphylaxis, and the sloughing of epithelial cells (9, 17, 37) . Surfactants and detergents can cause cell lysis and sloughing, whereas Ca 2ϩ chelators can cause cytoskeletal re-arrangements and interfere with calcium signaling pathways (37) . An additional drawback to these treatments is that, in general, there is little separation between the effective concentration and the cytotoxic concentration (37) . Alternatively, ZOT, which lacks many undesirable side effects, has been used to modulate the epithelial barrier in an experimental therapeutic setting (10) . The results are encouraging and provide a "proof of concept" indicating that intestinal tight junctions can be modulated to allow for the absorption of high-molecularweight therapeutic compounds without apparent deleterious side effects (10) . Other studies (5) have suggested that gene therapy might be augmented by transiently reducing epithelial tight junction integrity as well. Thus there is a great need to identify safe and efficient means by which to modulate the epithelial barrier function at the tight junction in a wider variety of epithelia.
The goal of the present study is to define the relationship between the apical exposure of epithelial cells to NC-1059, a channel-forming peptide, to changes in barrier function as typified by the increase in g TE and transepithelial solute permeability. Results suggest that the peptide provides a route for ion permeation across the cell membrane and modulates the paracellular pathway over a similar concentration range, although the time course of the two responses is dramatically different.
MATERIALS AND METHODS
Peptide synthesis. All peptides were synthesized by solid phase synthesis using 9-fluorenylmethoxycarbonyl chemistry as described in detail previously (31) . Peptides were purified and characterized by reverse-phase HPLC and matrix-assisted laser desorption time-offlight mass spectroscopy (MALDI-TOF).
Cell culture. MDCK cells were provided by Dr. Lawrence Sullivan (University of Kansas Medical Center, Kansas City, KS) and were maintained in culture as described previously (2) . Briefly, the culture medium was a 1:1 mixture of DMEM and Ham's F-12 (GIBCO BRL, Rockville, MD) supplemented with 5% heat-inactivated FBS (BioWhittaker, Walkersville, MD) and 1% penicillin and streptomycin (GIBCO BRL). Cells were grown in plastic 25-cm 2 culture flasks (Cellstar, Frickenhausen, Germany) in a humidified environment with 5% CO 2 at 37°C. Confluent cultures were dissociated for subculture with PBS containing 2.6 mM EDTA and 0.25% trypsin. For permeation and flux experiments, cells were seeded on 1.13-cm 2 permeable supports (Snapwell; Costar, Cambridge, MA) at a density of ϳ1 ϫ 10 6 cells/well and incubated in DMEM/F-12 supplemented with FBS and antibiotics (refreshed every other day) for 2-3 wk before cells were mounted in modified Ussing flux chambers for evaluation.
Electrical measurements. Transepithelial ion transport was evaluated in modified Ussing chambers (Model DCV9; Navicyte, San Diego, CA). For typical electrical measurements of ion flux, cells were bathed in symmetrical Ringer solution (composition in mM: 120 NaCl, 25 NaHCO 3, 3.3 KH2PO4, 0.8 K2HPO4, 1.2 MgCl2, 1.2 CaCl2; 290 Ϯ 2 mosmol/kgH2O). The diffusion chambers were maintained at 37°C and continuously bubbled with 5% CO2-95% O2 to maintain pH, provide aeration, and mix the fluid in the chambers. The transepithelial potential was clamped to zero, and I sc was measured continuously with a voltage-clamp apparatus (Model 558C; Department of Bioengineering, University of Iowa, Iowa City, IA). Data were acquired at 1 Hz with a Macintosh computer (Apple Computer, Cuppertino, CA) using Aqknowledge software (v. 3.2.6; BIOPAC Systems, Santa Barbara, CA) with an MP100A-CE interface. g TE was determined by exposing the epithelia to a 5-s, 1-mV, bipolar pulse at 100-s intervals. The recorded current deflections were used with Ohm's law to calculate g TE (gTE ϭ ⌬I/⌬V).
Alternative apical bathing solutions that allowed for the imposition of defined transepithelial ion gradients were employed for one set of experiments. Three solutions of virtually identical osmolality (280 -290 mosmol/kgH 2O) (15, 28, 30) . Briefly, sexually mature, human chorionic gonadotropin-treated Xenopus laevis were purchased (Xenopus 1, Ann Arbor, MI) and individually maintained in aquaria in an Association for Assessment and Accreditation of Laboratory Animal Care-accredited facility. Oocyte isolation was accomplished by using Institutional Animal Care and Use Committee-approved protocols in which Xenopus were anesthetized by exposure to MS-222 (Sigma, St. Louis, MO) and a laparoscopic approach was employed to isolate and remove the ovary. Oocytes were separated from follicular cells by incubation in nominally Ca 2ϩ -free ND-96 (in mM: 96 NaCl, 1 KCl, 1 MgCl2, 5 HEPES, pH 7.5) including 0.7 mg/ml collagenase (GIBCO BRL) and 0.1 mg/ml trypsin inhibitor (Sigma) on a low-speed rocker at room temperature for 35-60 min. Oocytes were rinsed five times and incubated in K2HPO4 (100 mM; pH 6.5) with BSA (0.1% wt/vol; Sigma) for 1 h with gentle agitation at 15-min intervals. Oocytes were then transferred to and maintained in modified Barth's solution [in mM: 88 NaCl, 2.4 NaHCO3, 1 KCl, 0.82 MgSO4, 0.41 CaCl2, 0.3 Ca(NO3)2, 10 HEPES, pH 7.5] at 18 -20°C until current recordings were made 1 to 5 days later.
Membrane conductance and permselectivity. The two-electrode voltage-clamp technique was employed. Oocytes were impaled with two 3-M KCl-filled electrodes having resistances of 0.5-2 M⍀. The electrodes were connected to a GeneClamp 500 current-voltage clamp amplifier (Axon Instruments, Foster City, CA) via Ag-AgCl pellet electrodes and referenced to a Ag-AgCl pellet that communicated to the bath via an agarose bridge (3% agarose in 1 M KCl). The voltage clamp was controlled by an analog-digital interface (Digidata 1200b) using a Pentium-based computer running pClamp software (version 9.0; Axon Instruments) for command potential and current and voltage recording. Two voltage-pulse protocols were employed. In the first, membrane potential (Vm) was held at Ϫ30 mV (approximately the resting Vm) and pulsed to Ϫ90 mV for 1,000 ms, returned to Ϫ30 mV for 1,000 ms, and then pulsed to 0 mV for 1,000 ms. This pulse protocol was repeated at 4,128-ms intervals throughout the experimental period to verify that stable conductance levels were achieved with each change of bath solution. Current-voltage (I-V) relationships were generated at the end of each treatment period (baseline, peptideexposed, ion-substituted) with a repeating three-step protocol. Vm was held at Ϫ30 mV for 500 ms, pulsed to one of nine voltages (Ϫ100 to ϩ60 mV in 20-mV increments) for 1,000 ms, and returned to Ϫ30 mV for 500 ms. The average voltage and current during the final 500 ms of each voltage pulse was used to construct each I-V relationship.
Data were recorded in solutions of four ionic compositions: ND-96 (in mM: 96 NaCl, 1 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES), reduced Na ϩ and Cl Ϫ (in mM: 173 mannitol, 9.6 NaCl, 1 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES), reduced Cl Ϫ (in mM: 92.3 Na-gluconate, 3.7 NaCl, 1 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES), and reduced Na ϩ (in mM: 86.4 NMDG⅐Cl, 9.6 NaCl, 1 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES). pH was adjusted to 7.5 for all solutions. The final osmolality of all solutions was between 185 and 200 mosmol/kgH2O. I-V relationships were initially recorded in ND-96 in the absence of any synthetic peptide. Peptide (8 l, 5 mM in H2O) was then added to the 400-l bath and mixed to attain a final concentration of 100 M. After stable parameters were attained (Ͻ5 min), an I-V relationship was again recorded. Subsequently, the bath composition was changed to an alternative ion composition by adding 200 l of the new solution, mixing, and removing 200 l of the bathing medium 15 times (Ͼ99.7% bath replacement). Peptide was again added to the bathing medium (100 M final concentration), and the stability of membrane conductance was verified before an I-V relationship was recorded. The bathing medium was repeatedly changed with this technique. In every case, however, recordings were made in ND-96 before (and typically after) recording in an alternative ionic composition to verify reversibility of bath composition-induced changes and to allow for comparisons to temporally close controls. Visual inspection suggested that a linear I-V relationship was present, as expected. Thus linear regression (Sigmaplot v. 2000 for Windows, SPSS, Chicago, IL; and Excel, v. 9.0.38, Microsoft, Redmond, WA) was employed to determine the slope conductance and reversal potential (V rev) in each condition. I-V relationships were mathematically adjusted for junction potentials by using the appropriate pClamp module. Permselectivity (P) for Cl Ϫ vs. Na ϩ was estimated by using Eq. 1, which is derived from the Goldman-Hodgkin-Katz constant field equation (13) P Cl :P Na ϭ
This analysis is based on changes (⌬) in Vrev that accompany a change in bath ionic composition with the underlying assumption that, in the presence of peptide, membrane conductance could be attributed to the peptide. The analysis further assumes that, since the concentration of other ions (e.g., K ϩ , Ca 2ϩ , Mg 2ϩ ) was relatively small and unchanged, overall permeation by these ions would minimally contribute to changes in V rev. e, F, R, and T have their conventional definitions. Subscript 1 indicates the ion activity in ND-96, whereas subscript 2 denotes the activity in reduced-NaCl ND-96.
FITC-dextran permeability assay. Epithelial permeability to uncharged solutes of various sizes was assessed with monolayers grown on Snapwell tissue culture inserts as described in Cell culture. Confluent monolayers were washed once with Ringer solution and placed in one of three treatments containing FITC-conjugated dextran (Sigma) in the apical compartment: 1) Ringer solution in the apical and basolateral compartments; 2) Ringer solution in the apical and basolateral compartments with NC-1059 (100 M) in the apical solution; or 3) EDTA (3 mM) in Ringer solution that was diluted 1:1 with distilled water in both the apical and basolateral compartments. Monolayers were incubated at 37°C for 60 min, and the solution in the basolateral well was sampled to quantify fluorescently labeled dextran. Monolayers were then washed with Ringer solution to remove peptide, EDTA, and dextran, placed in tissue culture medium, and returned to the incubator for 2 days before the assay was conducted again.
Confocal microscopy. Immunoreactivity to antibodies raised against tight junction-associated proteins was assessed by confocal microscopy (Zeiss, Thornwood, NY). Samples for visualization were prepared from monolayers used in electrophysiological studies. After being removed from Ussing chambers, monolayers were washed in Ringer solution and fixed overnight in 10% neutral buffered formalin. Monolayers were washed three times in PBS, permeabilized with 0.1% Triton X-100 in PBS, blocked with goat serum, and then exposed to primary antibody in a 1:500 dilution (rat anti-zonula occludens-1, catalog no. MAB120; Chemicon, Temecula, CA, or rabbit anti-occludin, catalog no. 71-1500; Zymed, San Francisco, CA) for 1 h at room temperature. After being washed three times in PBS, FITC-conjugated goat anti-rat (catalog no. AP136F; Chemicon) or goat anti-rabbit (catalog no. Fl-1000; Vector Laboratories, Burlingame, CA) secondary antibodies were employed (1:1,000 dilution) with exposure occurring for 1 h at room temperature. TRITC-labeled phalloidin (0.1 mg/ml in methanol; Sigma) used for F-actin localization was applied concurrently with the secondary antibody. A KrAr laser was used to excite the fluorophores. Filter sets used for fluorescein were band pass (BP) 485 Ϯ 20 nm for excitation and BP 515 Ϯ 540 nm for emission, and for rhodamine the sets used were BP 530 Ϯ 585 nm for excitation and long pass (LP) 590 nm for emission.
Chemicals and stock solutions. 1-EBIO (Acros; Fisher Scientific, Pittsburgh, PA) was prepared as a 1 M stock solution in DMSO. Forskolin (Coleus forskohlii) was purchased from Calbiochem (La Jolla, CA) and prepared as a 10 mM stock in ethanol. All other chemicals were purchased from Sigma and were of reagent grade unless otherwise noted. Unless otherwise stated, synthetic peptide was suspended in water at 5 mM just before experimental addition.
Data analysis. All results are presented as means Ϯ SE. Fitting of user-defined functions to data sets was conducted with Sigmaplot. The difference between treatment groups was analyzed by using Student's t-test (Microsoft Excel 2002). The probability of making a type I error Ͻ0.05 is considered statistically significant. The reported value of n is the number of independent observations.
RESULTS

NC-1059 mediates ion transport in a concentration-dependent manner.
NC-1059 causes a concentration-dependent increase in I sc (indicative of anion secretion or cation absorption) and g TE across MDCK epithelial monolayers (2). Thus experiments have been conducted to determine if the concentration dependence is similar for these two outcomes. Epithelia were pretreated with 1-EBIO to fully activate basolateral potassium channels in all preparations and thus maximize the electrochemical driving force for ion transport (2) . As previously reported, 1-EBIO has no effect on either I sc or g TE , suggesting that under basal conditions the basolateral membrane of MDCK cells is neither rate limiting for anion secretion nor the primary determinant of transepithelial resistance (Fig. 1, A and  B) . Apical exposure to NC-1059 (100 M) results in a rapid increase in I sc that reaches a peak value before declining toward zero ( Fig. 1A ) with corresponding changes in g TE (Fig.  1B) . Basal g TE is low (Ͻ1 mS/cm 2 ), and exposure to NC-1059 results in an increase in g TE with a slower onset of effect than the increase in I sc . These results suggest that the conductive pathway that accounts for ion transport does not directly or fully account for the increase in g TE . However, the increase in g TE may contribute to the return of I sc toward zero by depolarization of the epithelial cells that reduces secondary active ion flux. There is also the possibility that, at extremely high g TE , any electrode offset or junction potential could affect I sc . Data similar to that presented in Fig. 1A , in which the change in I sc is plotted as a function of peptide concentration, have been reported previously (3) . The fit of a modified Hill equation to the data revealed a value for K 1/2 (50 M) that is fourfold lower than that reported for similar peptides (e.g., NK 4 -M2GlyR ϭ 208 Ϯ 6 M), although the predicted maximal short-circuit current (25.0 A/cm 2 ) is indistinguishable (24.3 Ϯ 0.5; Ref.
2). These results show that NC-1059 exhibits greater biological availability or efficacy than NK 4 -M2GlyR while maintaining channel-forming ability, a stated goal for the design of a CF therapeutic. Additionally, substantial increases in g TE are observed. Whereas the latter effect is not a targeted outcome, it is immediately obvious that NC-1059 provides unique research and therapeutic opportunities. Characterization of this effect provides the basis for the remainder of this report. and D. Results clearly show that g TE increases to a plateau value over the duration examined and that the peptide-induced increase in g TE is concentration dependent. To predict the maximal change in g TE and the time course of this change, data in Fig. 1D were fitted by a logistic equation. , which is approaching a practical limit for the assay system in that this conductance is one-third to one-half the electrical conductance of a culture insert in the absence of cells (70 -100 mS/cm 2 ). Values of g TEmax derived from the mathematical fits to the data are plotted as a function of peptide concentration in Fig. 1D . No indication of saturation is observed over the concentration range that could be tested. Whether a maximal g TE is reached cannot be determined effectively, because the observed conductance with 60 M is approaching the maximal observable conductance for the recording system.
NC-1059 causes concentration-dependent increase in
NC-1059-induced changes in g TE require apical exposure. Experiments were conducted to test for the relative efficacy of apical and basolateral NC-1059 on changes in ion transport and barrier function. Results presented in Fig. 2 demonstrate that apical exposure is required to observe a significant effect of the peptide on these parameters. Results from a typical experiment are presented in Fig. 2 , A-D. When apically exposed to NC-1059 (300 M), I sc rapidly increases to a peak value and then declines (Fig. 2, A and B) , whereas the increase in g TE is delayed (Fig. 2, C and D, consistent with Fig. 1) . Exposure of the basolateral membrane to NC-1059 produces no obvious effect, regardless of the order of exposure. Results from these and five additional monolayer pairs are summarized in Fig. 2E . On a pairwise basis, effects were never observed with basolateral exposure and were always observed with apical exposure. These results might suggest that NC-1059 interacts with a cellular component that is accessible only from the apical aspect of the monolayer, although additional experiments would be required to fully test this hypothesis.
NC-1059-induced changes in g TE are readily reversible. Data presented in Fig. 3 show that the peptide-induced increase in I sc and g TE can reverse over time either with or without washout of the peptide. In the presence of 1-EBIO, 60 M NC-1059 causes a typical rise in I sc (Fig. 3A) and g TE (Fig. 3B) . Following 30 min of exposure, the solution bathing the apical aspect of the epithelium was replaced with peptide-free Ringer solution and recording was continued for 5 h. Results show that the I sc and g TE return toward, but do not return to, pretreatment values during the duration of the recording. In this paradigm, monolayers respond to the subsequent addition of forskolin with an increase in I sc (data not shown), demonstrating that epithelia remain viable and responsive to cAMP-mediated stimulation following peptide exposure.
A separate MDCK monolayer was sequentially exposed to two concentrations of NC-1059 (35 and 100 M) with the recorded I sc and derived g TE presented in Fig. 3, C and D, respectively. Results clearly show that a submaximal increase in g TE is achieved and maintained for over 3 h in the presence of 35 M NC-1059. Such prolonged exposure is apparently without deleterious effects on the epithelium, because no evidence of epithelial deterioration is observed and responsiveness is maintained. Subsequent exposure to greater concentrations of NC-1059 (100 M final) further increases g TE and I sc to a value expected for this concentration (17 mS/cm 2 and 32 A/cm 2 ). It should be noted that, regardless of whether the peptide is removed from the bath, some reversal in both I sc and g TE is observed.
Experiments designed to determine whether the NC-1059 activity in solution declines over time were conducted, although it was previously reported that NC-1059 does not aggregate in solution, as was seen with related peptides (3). Results from a typical experiment are presented in Fig. 4 . Paired monolayers were mounted in Ussing chambers, with some being immediately exposed to NC-1059. NC-1059 (60 and 100 M) elicited expected increases in I sc and g TE that reversed over time. Sixty percent of the apical solution was then transferred from the apical side of a treated monolayer to an untreated monolayer, as indicated by the arrows (Fig. 4 , A to C and E to G). A previously untreated monolayer was exposed to 60 M of freshly dissolved NC-1059 at the same time (Fig. 4, D and H) . The results clearly demonstrate that active NC-1059 continued to be present in the apical solution even as the effects on I sc and g TE were reversing. The possibility remained that peptide activity was slowly decreasing such that the response declined incrementally as activity diminished. This possibility was excluded by experiments in which a peptide-induced response was generated and the apical solution was partially replaced with Ringer solution containing freshly dissolved peptide. No increment in either I sc or g TE was observed (n ϭ 3). Together, these results suggest that the effect of NC-1059 on MDCK electrical parameters is transient.
Additional experiments have been conducted to test for complete reversibility of peptide-induced changes in g TE . Monolayers were exposed to peptide (60 M) in an Ussing chamber for ϳ20 min to document increases in g TE , recovered, and returned to the cell culture incubator for 2-5 days with the apical and basolateral media refreshed daily before subsequent assessment of basal g TE and responsiveness to peptide. Results presented in Fig. 5 , A-C, show the time course of changes in g TE for three typical monolayers that were repeatedly exposed to NC-1059 at 2-, 3-, and 4-day intervals, respectively. Solid arrows indicate the effect of NC-1059, whereas the dashed arrows indicate the return to pretreatment values that is observed before a subsequent exposure. In all cases g TE is Ͻ2 mS/cm 2 at baseline, increases to Ͼ15 mS/cm 2 with peptide exposure, and returns to Ͻ2 mS/cm 2 before the subsequent assessment. Regardless of the duration between peptide exposures (2, 3, or 4 days), g TE of previously treated monolayers returns to pretreatment values and is indistinguishable from that of untreated monolayers (not shown). Some monolayers have been exposed to peptide as many as eight times over a 16-day period with no change in pretreatment g TE and no diminution of responsiveness. Data from four to eight monolayers at each time point are summarized in Fig. 5D . Results demonstrate that g TE after as little as 2 days of incubation in peptide-free medium is indistinguishable from untreated mono- 
NC-1059-induced changes in g TE occur in the absence of small monovalent ions.
Experiments have been conducted to test for effects of changing the primary anion and/or cation in the solution bathing the apical aspect of the epithelium. Substitution of apical Na ϩ with NMDG ϩ , a cation that fails to permeate most Na ϩ -and/or K ϩ -selective channels, alters the kinetic profile for NC-1059-induced effects (Fig. 6B ) compared with a paired control (Fig. 6A) . Exposure to NC-1059 was associated with a rapid increase in I sc that reached a maximum in Ͻ2 min (i.e., more rapidly than in control conditions) and then reversed polarity to achieve strong negative I sc (note that there is a break in the ordinate) for the duration of the experiment. Likewise, substitution of Cl Ϫ by gluconate is associated with quantitative and qualitative differences in the NC-1059 response profile (Fig. 6C) . NC-1059 causes a substantially larger increase in I sc than in control conditions, and the elevated I sc is maintained for the duration of the experiment. Finally, substitution of both Na ϩ and Cl Ϫ provides a response profile that more closely approximates the control conditions (Fig. 6D) . Regardless of the ions present in the apical solution, similar profiles for the increase in g TE are observed (Fig. 6E) . Together, the results are consistent with NC-1059 being a nonselective or modestly anion-selective channel at the apical membrane that subsequently induces the operation of a pathway that allows for selective permeation by Na ϩ and Cl Ϫ relative to NMDG ϩ and gluconate, respectively. These conclusions are based on the observations that, in the absence of apical Na ϩ and with no anion gradient, one might expect Na ϩ secretion through a nonselective ion channel. Such activity would result in a negative I sc . However, I sc initially 5 . Effect of NC-1059 on gTE is both transient and repeatable. gTE was determined before and after MDCK cell monolayers were exposed to 60 M NC-1059 on a treatment day. After each exposure, monolayers were removed from the Ussing chamber and returned to the incubator for 2, 3, 4, or 5 days before again being evaluated and exposed to NC-1059. A-C: representative data from individual monolayers exposed to NC-1059 at 2-, 3-, and 4-day intervals, respectively. increases in response to NC-1059, which is consistent with anion secretion but not cation secretion. Subsequently, I sc becomes negative, consistent with gradient-driven Na ϩ secretion through a pathway that is selective for Na ϩ over NMDG ϩ . In this condition, any ongoing anion secretion would reduce the I sc magnitude. In the absence of apical Cl Ϫ , the acute effect of NC-1059 on I sc is enhanced, as would be expected for an increased electrochemical driving force for anion secretion. I sc reaches a transient plateau and then continues to increase. A sustained elevation in I sc that is consistent with ongoing anion secretion (likely both gradient-driven and active transport) is observed throughout the experiment. Finally, in the absence of both Na ϩ and Cl Ϫ in the apical solution (where similar gradient-driven forces for Na ϩ and Cl Ϫ secretion would be present), the response profile is similar to the control conditions in which concentration gradients are not present. g TE does not increase to the same magnitude in Cl Ϫ -free conditions, an outcome that would be expected if a portion of the conductance change depended on permeation through Cl Ϫ -selective channels. Together the results suggest that the initial increase in I sc reflects anion (i.e., Cl Ϫ ) secretion, whereas extended effects exhibit little selectivity between Cl Ϫ and Na ϩ , although larger anions (e.g., gluconate) and cations (e.g., NMDG ϩ ) are less permeant through this pathway.
NC-1059 is modestly Cl
Ϫ permselective. Xenopus oocytes have been employed to further test for permselectivity of NC-1059 ion channels in the absence of confounding effects associated with permeation through a noncellular (i.e., paracellular) pathway and the inability to set the electrochemical driving force. Typical results showing the NC-1059-induced increase in membrane conductance and ion-dependent change in V rev are presented in Fig. 7, A and B , with results from numerous experiments being summarized in Fig. 7, C and D. The results indicate that exposure to NC-1059 is associated with a Ͼ18 Ϯ 4-fold increase in membrane conductance (n ϭ 6). Concomitant reduction in bath Na ϩ and Cl Ϫ is associated with a rightward shift in V rev of 5.2 Ϯ 0.6 mV. Substitution of Cl Ϫ by gluconate is associated with a greater rightward shift (8.4 Ϯ 2.1 mV), whereas substitution of Na ϩ by NMDG ϩ is associated with a 4.2 Ϯ 1.7-mV leftward shift. A synthetic peptide of similar amino acid composition, but in random order, has no effect on membrane conductance. Similarly, changes in bath ion composition have little effect on membrane conductance or on V rev in the absence of NC-1059 (not shown). Together, these results indicate that the NC-1059-induced conductance has a finite permeability for both Cl Ϫ and Na ϩ . There is, however, little permselectivity between these monovalent ions. Mathematical analysis employing Eq. 1 indicates a Cl Ϫ -to-Na ϩ permselectivity of 1.29 Ϯ 0.04. Experiments in which these small monovalent ions are singly substituted support this conclusion in that a greater rightward shift in V rev is observed with Cl Ϫ substitution than the leftward shift observed with Na ϩ substitution. Oocyte results support observations made with intact monolayers by functionally demonstrating the membrane insertion of a permeation pathway that is modestly selective for Cl Ϫ over Na ϩ . Results from this assay do not, however, address the possibility that a paracellular pathway might be directly or indirectly affected by peptide exposure.
NC-1059 allows permeation of 9.5-kDa FITC-dextran conjugate. Experiments have been conducted to determine if NC-1059-induced changes in g TE are mirrored by changes in permeation of larger, nonionic solutes. As shown in Fig. 8 , NC-1059 exposure caused a substantial increment in transepithelial flux of FITC-labeled 9.5-kDa dextran over a 60-min assay period, although it was less than half of that observed across paired monolayers exposed to 3 mM EDTA in hypotonic Ringer solution (50% dilution with H 2 O). Tissue culture inserts are permeant to all sizes of dextran tested (up to 2.5 MDa; Fig. 8, inset ). These results demonstrate that the NC-1059-stimulated increase in g TE is paralleled by an increase in concentration gradient-driven transepithelial flux of large, uncharged solutes. The lack of permeation by 77-kDa and larger solutes suggests that the NC-1059-associated permeation pathway has a finite maximal diameter or that the pathway exhibits some form of selectivity, an observation that is consistent with I sc measurements reported above for bi-ionic conditions.
NC-1059-treated monolayers are transiently permeant to 9.5-kDa dextran. Experiments have been conducted to determine whether, like changes in g TE , the NC-1059-induced increase in permeability to 9.5-kDa dextran is both reversible and repeatable. Results presented in Fig. 9 verify earlier observations by showing that the two treatments, NC-1059 and EDTA/hypotonic Ringer solution, are associated with elevated permeation of 9.5-kDa FITC-dextran conjugate (compare re- 8 . Apical application of NC-1059 (100 M) allows a 9.5-kDa FITCdextran conjugate to permeate an MDCK monolayer while excluding larger molecular weight conjugates. Application of EDTA (3 mM) in hypotonic Ringer solution (50% dilution) allows access to the basolateral compartment for all FITC-dextran conjugates tested. Permeation across paired monolayers in the absence of treatment was subtracted to show treatment-induced changes in dye permeation. Assay was performed in triplicate, and results are typical from 3 similar experiments. Inset: permeation of FITC-conjugated dextran across a tissue culture support in the absence of cells. FITC-dextran conjugates permeate the tissue culture support at ϳ1,000-fold higher rate than in the presence of cells. Fig. 9 . NC-1059-induced FITC-conjugated dextran (9.5 kDa) permeation across MDCK epithelial cell monolayers is reversible and repeatable. Dextran permeation was evaluated across MDCK cell monolayers that were treated on day 1 with NC-1059 (100 M), EDTA (6 mM in hypotonic Ringer solution), or an untreated control monolayer (12 monolayers per condition assayed in triplicate). Cell monolayers were washed and incubated for 2 days in culture media, and then subsets from each previous treatment (4 monolayers per condition) were exposed to 1 of the 3 treatments. Results are typical from 2 similar experiments. sults of initial treatment). All monolayers were washed after the response was assessed and were returned to the incubator in typical medium for subsequent experiments 2 days later. Monolayers from each of the three initial treatments were divided and exposed in parallel to each of the three treatments. Results demonstrate that, regardless of initial treatment and the magnitude of dye permeation, 2 days of recovery allow for the reformation of tight epithelial barrier. In each case, when monolayers were exposed to control conditions, a minimal amount of dextran permeation was observed, indicating that dextran permeability returns to a value that is indistinguishable from untreated monolayers within 2 days. Furthermore, the results demonstrate that the results of the three treatments are not affected by previous exposure to either NC-1059 or EDTA. In each treatment group, EDTA exposure was associated with the highest level of permeation. Permeation in the presence of NC-1059 is significantly greater than control but less than EDTA in each treatment group. The results show that apical NC-1059 exposure of MDCK monolayers causes a transient increase in permeability to uncharged solutes of up to 9.5 kDa, with no long-term deficit in epithelial barrier function observed. Fig. 10 show the immunolocalization of tight junction-associated proteins using confocal microscopy. Protein components of the tight junction selected for analysis were actin, a cytoskeletal component that forms the junction-associated actomyosin ring; ZO-1, a putative scaffold protein that anchors the junctional complex to the cytoskeleton; and occludin, a transmembrane protein involved in tight junction formation. Compared with untreated controls, the distribution of actin, occludin, and ZO-1 immunoreactivity in MDCK monolayers was unchanged by exposure to NC-1059. Dense immunoreactivity for each tight junction constituent is observed to circumscribe all epithelial cells when viewed en face. Additionally, punctate intracellular occludin immunoreactivity is observed at the same focal plane, and diffuse ZO-1 immunoreactivity that appears to be associated with the nucleus is observed. Alternatively, exposure of epithelial cell monolayers to EDTA and hypotonic Ringer solution, a solution commonly employed to reduce junctional integrity and to disrupt cells from culture substrates, is associated with profound changes in localization of the perijunctional actin ring as well as the distribution of ZO-1. EDTA- treated cells appear to have "rounded up," and vacant areas in the field suggest that some cell sloughing occurs with this treatment.
Distribution of tight junction-associated proteins is unaltered by exposure to NC-1059. Data presented in
1 ZO-1 immunoreactivity remains largely associated with the cell membrane but appears to be somewhat more diffuse than peptide-treated or untreated controls. Protein distribution in monolayers exposed to a non-channel-forming peptide (scrambled) of similar amino acid composition to NC-1059 is indistinguishable from that observed in vehicletreated control monolayers, with cell-to-cell contacts apparently being maintained. These results suggest that the NC-1059-associated change in g TE results from tightly controlled changes in the paracellular pathway because large, uncharged solutes can readily permeate the epithelium without any apparent change in the distribution of tight junction-associated proteins or any indication of cell sloughing.
DISCUSSION
NC-1059 was synthesized as part of an ongoing program to develop synthetic peptides that form anion-selective channels in epithelial monolayers as potential therapeutics for CF. The rationale for the synthesis of this peptide was to determine if separate domains contribute to aggregation in aqueous solution and assembly of the peptide in cell membranes (3) . This peptide is remarkable in that it remains monomeric in aqueous solution yet partitions into cell membranes and supports ion transport across the cell membrane and thus across epithelial cell monolayers. NC-1059 acts to increase the I sc across MDCK monolayers, with a K 1/2 of ϳ40 M, which is fourfold less than that of NK 4 -M2GlyR (2), a sequence from which it was developed. Observations made during these experiments initially suggested that NC-1059 also modulates epithelial tight junctions. Although not a target of the design process, this effect holds great therapeutic and research potential.
NC-1059 induces a concentration-dependent increase in I sc across epithelial cell monolayers with a concurrent increase in g TE . This peptide is the only sequence designed so far that has demonstrated the ability to increase g TE to this magnitude, which is in excess of conductance changes expected for apical channel formation, because related peptide sequences provide comparable increases in I sc but do not exhibit the dramatic effects on transmural conductance (3). This additional functionality suggests that the ability of the peptide to support anion secretion is separate from, but perhaps related to, the effect on g TE .
The mechanism by which NC-1059 modulates g TE is unclear. The simplest interpretation, that NC-1059 forms conductive pores in the apical membrane that fully account for the change in g TE , is inadequate. Similar peptide sequences (i.e., with the first 16 amino acid residues being identical) cause an equal increase in I sc across MDCK epithelial monolayers but do not affect transepithelial resistance to the same extent (3).
Comparison of the data presented in Fig. 1D to an earlier report (3) shows that the concentration dependence for changes in g TE is right shifted compared with the concentration dependence of I sc . Additionally, permeation of 9.5-kDa dextran across the epithelium strongly suggests that a paracellular rather than a transcellular route is involved. A second simple possibility that can be discounted is that NC-1059 is cytotoxic and that a loss of cells accounts for the change in g TE (1) . Visual inspection provides no indication that cells are absent from the epithelium following NC-1059 exposure as they are following EDTA exposure. Furthermore, tight junction proteins are not redistributed in response to NC-1059, and both the selectivity (Na ϩ Ͼ NMDG ϩ ; Cl Ϫ Ͼ gluconate) and the finite size of the permeation pathway (9.5 but not 77 kDa dextran) suggest that a selective paracellular pathway is opened. Rather, the results suggest a specific interaction of NC-1059 with the cellular components involved in modulating g TE . This conclusion is bolstered by the "sidedness" of effects in that changes in electrical parameters are observed only with apical exposure. There is clearly precedence for metabotropic receptors selectively modulating the size exclusion of the paracellular pathway (21, 37) , although evidence has not yet been acquired to suggest a metabotropic effect of NC-1059.
That NC-1059 is effective only from the apical aspect of the epithelium suggests that a "receptor-type" mechanism might be involved. There is at this time, however, no definitive evidence to support such a claim. Results presented in Fig. 2 might indicate that there is limited access of the peptide across the tissue culture support. However, the membrane was permeable to 2.5 MDa, and 77-kDa dextran permeated the membrane in the presence of cells following EGTA exposure. Thus size exclusion by the culture support is unlikely. An alternative to the "receptor" hypothesis is that the apical membrane exhibits a unique lipid milieu with which NC-1059 interacts. This possibility by necessity includes the supposition that a similar milieu must be present in Xenopus oocytes because NC-1059 quite effectively modulated membrane conductance in this system. A third possibility is that NC-1059 exhibits pleiotropic effects by interacting at multiple cellular sites. At this time it remains unclear whether channel formation (i.e., ion transport) is a prerequisite for modulation of g TE . The possibility exists that NC-1059 may interact with the apical membrane to form ion channels by mechanisms similar to those that have been indicated for closely related peptides and that effects on g TE require interaction with another epithelial target.
The NC-1059-induced change in g TE is transient in nature, reaching a peak value within the first 10 -30 min of exposure. Several events might account for the transient nature of the response. It is possible that, due to charge neutralization or shielding, the peptide may undergo some aggregation and/or precipitation in Ringer solution (31) , thus reducing the effective concentration. It was previously reported (3) that NC-1059 (initially termed NK 4 -Ala) does not aggregate in solution. However, the analysis was conducted with H 2 O as the solvent instead of Ringer solution. The ionic strength of the Ringer solution may promote peptide aggregation (a competing and irreversible reaction) that would tend to decrease the effective concentration of NC-1059 in the bath and in the cell membrane. Alternatively, the response may diminish due to protease degradation of the peptide, in turn due to uptake of peptide from the apical membrane that subsequently leads to proteolysis. Data presented in Fig. 4 suggest that peptide aggregation or inactivation cannot account for the transient nature of the effects. The possibility remains that there may be some downregulation of the metabolic process that modulates 1 Multiple peptide-treated and control monolayers were surveyed over numerous microscope fields to determine whether any evidence of cell sloughing could be identified in either of these conditions. A confluent monolayer was observed in all cases. junction integrity. Data presented in Fig. 3 argue against this latter possibility in that the response to a submaximal concentration remains above baseline for at least 2 h and the epithelium subsequently responds to a higher concentration of NC-1059. Nonetheless, these and other possibilities may in part account for the transient nature of the response; additional experiments must be conducted to more fully evaluate these hypotheses.
There are numerous clinical situations in which modulation of an epithelial barrier presents therapeutic benefits. Drug absorption across intestinal, airway, or dermal epithelium could be enhanced with transient decreases in barrier function, making oral, inhaler, or topical administration of what are now parenteral drugs possible (9, 11) . Oral or inhalant formulations of medications such as insulin would be less expensive to produce and more easily delivered than parenteral formulations (37) . The permeability of the small intestinal epithelium to both insulin and immunoglobulin G was increased in rabbits when coadministered with ZOT (11) . However, ZOT is limited in its therapeutic application because it is only effective in the small intestine (10) . Additionally, ZOT is a 45-kDa protein that must be recombinantly produced and purified, although it has been shown that the majority of biological activity can reside in the COOH-terminal 15-amino acid segment (6) . The M2GlyR-derived peptides are Ͻ3 kDa and can be prepared synthetically or recombinantly expressed.
Gene therapy for epithelium-associated diseases such as CF provides a second therapeutic setting in which modulation of transepithelial permeability is desirable (24, 32) . Stable transfection of DNA sequences into epithelial cells in culture (7, 27) provides proof that genetic epithelial diseases can be treated or cured. However, bronchiolar epithelial cell viral receptors are located primarily in the basolateral membrane (17, 25, 38, 39) , leading to a low efficiency of gene transfer from apical exposure to viral vectors. Thus high viral titers and long incubation times are required to increase transfection efficiency, which can lead to a decrease in the effectiveness of repeated treatments. Increased transfection efficiency has been achieved with some chemical modulators of tight junctions (e.g., EGTA, perfluorochemicals, fatty acids), although these treatments were sometimes associated with inflammation (5, 17) . Modulators of epithelial barrier function would be the ideal agents to augment gene therapy, provided that they have a rapid onset, transient duration of action, and favorable safety profile, and do not decrease viral titer (35) . Initial observations with NC-1059 suggest that it may fulfill these criteria, although additional experiments will be required to determine whether viral access is limited due to size exclusion (i.e., Ͻ77 kDa). Additional experiments would also be required to test for inflammation. In this regard it is encouraging that similar effects on g TE have been observed when an all-D-amino acid form of NC-1059 was used (unpublished observations).
NC-1059 also presents the potential for developing an increased understanding of physiological and pathophysiological processes that modulate tight junctions. Various epithelia throughout the body exhibit transepithelial electrical resistances that vary over four orders of magnitude (37) , some of which change depending on the hormonal state (e.g., mammary; Refs. 22, 29) or physical environment (e.g., small intestine following a meal; Ref. 23 ). Signaling pathways that affect the paracellular pathway are not fully defined for any epithelium, and it is not known which mechanisms are broadly applicable and which are species or tissue specific. In this regard, it is noteworthy that NC-1059 stimulates g TE across male porcine reproductive epithelia, porcine ileal epithelia (IPEC-J2), and human colonic epithelia (Caco-2; unpublished observations). Thus, unlike ZOT, which affects only the small intestine (11), NC-1059 affects a broader spectrum of epithelia and, unlike Clostridium perfringens enterotoxin (19) , causes no discernible cell damage. Thus NC-1059 can be used to survey a variety of tissues to identify common regulatory mechanisms.
In summary, NC-1059 is a channel-forming peptide that reversibly modulates conductance through the epithelial paracellular pathway. The response is fully repeatable and occurs without overt indications of cytotoxicity. This functionality provides a unique opportunity to conduct research regarding the mechanisms that selectively modulate tight junction maintenance. Additionally, NC-1059 represents a novel lead compound that might be developed to augment other forms of therapy that are currently limited by the epithelial barrier.
